ArticleJournal of imaging2026
LTPNet: Lesion-Aware Triple-Path Feature Fusion Network for Skin Lesion Segmentation.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficient Dermoscopic Lesion Segmentation via Multi-Directional State-Space Modeling and Frequency-Aware Boundary Refinement.Journal of imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin lesion segmentation has achieved notable progress in recent years; however, accurate delineation remains challenging due to complex backgrounds, ambiguous boundaries, and low lesion-to-skin contrast. To address these issues, we propose the lesion-aware triple-path feature fusion network (LTPNet), an end-to-end framework that progressively processes features through extraction, refinement, and aggregation stages. In the extraction stage, we incorporate a general foreground-background attention to suppress background interference and accelerate model convergence. In the refinement stage, we introduce an attentive spatial modulator (ASM) to jointly exploit local structural cues and global semantic context for precise spatial modulation. We further develop a lesion-aware lite-gate attention (LALGA) module that performs local spatial feature modulation and global channel recalibration tailored to lesion characteristics. In the aggregation stage, we propose a triple-path feature fusion (TPFF) module that explicitly models feature relationships across scales via three complementary pathways: a common path (CP) for semantic consistency, a saliency path (SP) for highlighting co-activated regions, and a difference path (DP) for accentuating structural discrepancies. Extensive experiments on in-domain and cross-domain datasets show that LTPNet achieves superior segmentation accuracy with reasonable inference efficiency and model complexity, demonstrating its potential for efficient and reliable clinical decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.